CN107441474A - A kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof - Google Patents

A kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof Download PDF

Info

Publication number
CN107441474A
CN107441474A CN201710707797.2A CN201710707797A CN107441474A CN 107441474 A CN107441474 A CN 107441474A CN 201710707797 A CN201710707797 A CN 201710707797A CN 107441474 A CN107441474 A CN 107441474A
Authority
CN
China
Prior art keywords
gel
situ
cough
magnetite
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710707797.2A
Other languages
Chinese (zh)
Inventor
贾永艳
冯青云
王辉
徐如冰
韩志芳
田效志
王磊
韩德恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan University of Traditional Chinese Medicine HUTCM
Original Assignee
Henan University of Traditional Chinese Medicine HUTCM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan University of Traditional Chinese Medicine HUTCM filed Critical Henan University of Traditional Chinese Medicine HUTCM
Priority to CN201710707797.2A priority Critical patent/CN107441474A/en
Publication of CN107441474A publication Critical patent/CN107441474A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268Asarum (wild ginger)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/83Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835Aquilaria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to Chinese medicine compound prescription situ-gel for the treatment of cough and asthma and preparation method thereof, can effectively solve the problems, such as the medication of cough and asthma, its technical scheme solved is that situ-gel of the present invention is made up of the material medicine of following weight meter:The 15g of semen brassicae 5, the 15g of magnetite 5, the 10g of agalloch eaglewood 3, the 10g of rhizoma zingiberis 2, the 3g of asarum 1, the 9g of Chinese cassia tree 2, the 8g of PLURONICS F87 1, the 15g of poloxamer188 5, the 3g of azone 0.5, the 5g of glycerine 1 and the 80g of water 25, the present invention can effectively treat the diseases such as cough, expectoration, main temperature compensation lung qi, act on by phlegm drink, promoting flow of qi and blood circulation etc., it is curative for effect, securely and reliably, be treat cough and asthma medicine on innovation.

Description

A kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof
Technical field
The present invention relates to field of medicaments, particularly a kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof.
Background technology
Chronic bronchitis is that a kind of number of patients is more, and the disease of course of disease length, clinical symptoms are cough, expectoration, are had a strong impact on The labour capacity and quality of life of patient.Western medical treatment is mainly bronchodilator, glucocorticoid, training at present And long term oxygen therapy etc., but prolonged application bronchodilator or glucocorticoid erious adverse reaction, easily produce drug resistance and poison Side effect and the repeated infection for not being avoided that patient, cause state of an illness progressive to aggravate, make the quality of life degradation of patient, Even threat to life.Treatment by Chinese herbs is how not fully up to expectations with peroral dosage form, such as granule, mixture, oral liquid, curative effect.Chinese medicine Point application therapy is a kind of unique effective treatment method for creating and growing up with reference to acupuncture point and medicine effect, is had The percutaneous absorbtion of medicine and the double treatment characteristic of meridian point effect.With endo-medicine therapy toxicity and drug resistance Increase, point application therapy is increasingly subject to pay attention to.In-situ gel occurs in agents area immediately after being administered with solution state Phase in version, the semisolid preparation of the non-chemical crosslinking of formation is strong with agents area particularly mucous membrane tissue affinity, during delay Between it is long, be remarkably improved curative effect, increase the compliance of patient.Acupuncture point has point medicine and original with Chinese medicine compound prescription in-situ gel preparation Position gel two-fold advantage.Therefore, the problem of improvement treated on the medicine of cough and asthma is current urgent need to resolve.
The content of the invention
For the above situation, to solve the defect of prior art, the purpose of the present invention is just to provide a kind of cough and asthma for the treatment of Chinese medicine compound prescription situ-gel and preparation method thereof, can effectively solve the problems, such as the medication of cough and asthma.
The technical scheme that the present invention solves is that situ-gel of the present invention is made up of the material medicine of following weight meter:In vain Mustard seed 5-15g, magnetite 5-15g, agalloch eaglewood 3-10g, rhizoma zingiberis 2-10g, asarum 1-3g, Chinese cassia tree 2-9g, PLURONICS F87 1-8g, pool The 5-15g of Luo Shamu 407, azone 0.5-3g, glycerine 1-5g and water 25-80g.
The preparation method of situ-gel, comprises the following steps:
(1)The preparation of medicine:
Take rhizoma zingiberis, asarum, Chinese cassia tree, agalloch eaglewood to put in extraction kettle, extracting pressure 15Mpa, 30 DEG C of temperature, extract 3h;Temperature rises to 50 DEG C, pressure 15MPa, extract 2h;Pressure 25Mpa is adjusted, 30 DEG C of temperature, extracts 2h, collects extract, it is standby;
1-3g semen brassicaes are crushed, 100 mesh sieves is crossed, obtains semen brassicae powder, it is standby;4-12g semen brassicaes add the quality of 10 times of weight dense Spend and extracted 3 times, each 1h for 70% alcohol reflux, filtering, merging filtrate, reclaim ethanol, concentration, obtain semen brassicae medicinal extract(Per 1g Equivalent to 2 ~ 5g of crude drug), it is standby;
Magnetite adds the water of 8 times of weight, and extraction twice, each 1.5h, filtering, merging filtrate, reclaims ethanol, concentration, obtains magnetite leaching Cream, it is standby;
(2)The preparation of situ-gel:
PLURONICS F87, poloxamer188 are slowly added in water, it is complete in 4 DEG C of swellings, mix, add above-mentioned extract, Semen brassicae powder, semen brassicae medicinal extract, magnetite medicinal extract, azone, glycerine, it is well mixed, produces.
The present invention can effectively treat the diseases such as cough, expectoration, main temperature compensation lung qi, act on by phlegm drink, promoting flow of qi and blood circulation etc., It is curative for effect, it is the innovation on the medicine for treat cough and asthma securely and reliably.
Embodiment
The embodiment of the present invention is described in further detail with reference to embodiments.
Embodiment 1
The present invention in the specific implementation, can be made up of the material medicine of following weight meter:It is semen brassicae 9g, magnetite 9g, agalloch eaglewood 5g, dry Ginger 5g, asarum 3g, Chinese cassia tree 5g, PLURONICS F87 3g, poloxamer188 11g, azone 2g, glycerine 3g and water 50g.
Embodiment 2
The present invention in the specific implementation, can also be made up of the material medicine of following weight meter:Semen brassicae 5g, magnetite 5g, agalloch eaglewood 3g, Rhizoma zingiberis 2g, asarum 2g, Chinese cassia tree 2g, PLURONICS F87 1g, poloxamer188 5g, azone 0.5g, glycerine 1g and water 25g.
Embodiment 3
The present invention in the specific implementation, can also be made up of the material medicine of following weight meter:Semen brassicae 15g, magnetite 15g, agalloch eaglewood 10g, rhizoma zingiberis 9g, asarum 7g, Chinese cassia tree 9g, PLURONICS F87 8g, poloxamer188 15g, azone 3g, glycerine 5g and water 80g.
Embodiment 4
The present invention in the specific implementation, can also be made up of the material medicine of following weight meter:Semen brassicae 3-9g, magnetite 6-8g, sink Fragrant 4-7g, rhizoma zingiberis 3-6g, asarum 1.5-2g, Chinese cassia tree 3-5g, PLURONICS F87 2-5g, poloxamer188 6-8g, azone 0.4-1.9g, glycerine 1-3g and water 25-50g.
Embodiment 5
The present invention in the specific implementation, can also be made up of the material medicine of following weight meter:Semen brassicae 10-15g, magnetite 9-15g, Agalloch eaglewood 8-10g, rhizoma zingiberis 7-9g, asarum 2-3g, Chinese cassia tree 6-9g, PLURONICS F87 6-8g, poloxamer188 9-15g, azone 2-3g, glycerine 3-5g and water 50-80g.
Above-mentioned component supported mutually through science, reasonable compatibility, effective for the treatment of cough and asthma, good effect, and drug safety, And obtained fully proving through clinical data, relevant clinical data is as follows:
1 clinical data
The standard sight case totally 60 of 1.1 selection cases, single-blind randomized are divided into 2 groups for the treatment of group, control group, every group each 30. Man 15 in treatment group, female 15 are 35~65 years old age, average 43 years old.Control group 30, man 17, female 13, age 30- It is 65 years old, average 41 years old.Two groups sex, age, the course of disease and type distribution etc. without significant difference, there is comparativity.
1.2 diagnostic criteria
According to clinical symptoms, meet region, seasonality, acute and chronic bronchitis (old-slow-bronchial tube), allergic bronchial asthma, The disease based on cough and asthma such as pulmonary emphysema, pulmonary heart disease.
2 therapeutic schemes
2.1 control group sustained-release theophylline capsules, 100 mg/time, 2 times/d, orally.
2.2 treatment groups add with cough and asthma situ-gel of the present invention, every 5 days 1 time on the basis of above-mentioned treatment, be affixed on Tiantu, Dingchuan (double caves), big vertebra, Danzhong, fei shu.Two groups of courses for the treatment of are 30 days.
3 observation index and statistical method
3.1 observation index PFTs.
The general physical examination project of 3.2 safety indexes(Body temperature, blood pressure, breathing, pulse), blood urine is conventional, darling renal function inspection Look into, with begin a project before medication and clinical research terminate after it is each check once, observe adverse reaction at any time.
3.3 statistical method total datas use mean ± standard deviation through SPSS10.0 software processings, measurement data (x±s)Represent, measurement data is examined using t, and enumeration data uses chi-square criterion.
4 criterions of therapeutical effect and treatment results
4.1 therapeutic evaluation
It is effective:Cough up phlegm, pant and other diseases are cured, experimental check is clearly better.
Effectively:Cough, cough up phlegm, panting and other diseases are taken a turn for the better, laboratory examination makes moderate progress.
It is invalid:Primary symptom does not change or deteriorated.
Two groups of Clinical efficacy comparison changes are shown in Table 1 after 4.2 treatments
1 two groups of patient's curative effects of table compare
Group It is effective Effectively It is invalid Total effective rate
Treatment group(30) 17 11 2 93.33%
Control group(30) 17 8 5 83.33%
As seen from Table 1, in 30 patients for the treatment of group, effective 17, effective 11, invalid 2, total effective rate 93.33%%;It is right According to group 30 patients in, effective 17, effective 8, invalid 5, total effective rate 83.33%.Statistical method:Using SPSS10.0 statistical softwares, are examined using t, and enumeration data uses chi-square criterion precise probabilistic method, P<0.05 is that difference has statistics Learn meaning.
4.2 safety indexes observe the general physical examination project of two groups of patients, blood urine routinely inspection before and after this clinical observation treatment Look into, cardiac inspection etc. has no significant change.Two groups of patients examine through t, and two groups of pretherapy and post-treatment hepatic and renal functions and blood routine are related Index is without significant difference, P>0.05, prompt to have no significant effect hepatic and renal function and blood picture during two groups of medications.
5 conclusions
Acupuncture point of the present invention has point medicine and in-situ gel two-fold advantage with Chinese medicine compound prescription in-situ gel preparation, is remarkably improved Curative effect, increase the compliance of patient, suitable for region, seasonality, acute and chronic bronchitis (old-slow-bronchial tube), anaphylaxis branch gas The disease based on cough and asthma such as pipe asthma, pulmonary emphysema, pulmonary heart disease, and the present invention mutually ties Modern preparations technology with situ-gel Close, prepare novel percutaneous preparation, the present invention is administered with liquid condition, semi-solid gel is formed in agents area, with skin Affinity is strong, has that excitant is small, long action time, prepares that simple, easy to use, dosage is easily controllable, increases the suitable of patient The advantages that answering property, it is to treat the innovation on cough and asthma medicine, there is actual clinical meaning and good application value.

Claims (7)

1. a kind of Chinese medicine compound prescription situ-gel for treating cough and asthma, it is characterised in that the situ-gel is by the original of following weight meter Material medicine is made:Semen brassicae 5-15g, magnetite 5-15g, agalloch eaglewood 3-10g, rhizoma zingiberis 2-10g, asarum 1-3g, Chinese cassia tree 2-9g, Bo Luosha The 1-8g of nurse 188, poloxamer188 5-15g, azone 0.5-3g, glycerine 1-5g and water 25-80g.
2. the Chinese medicine compound prescription situ-gel for the treatment of cough and asthma according to claim 1, it is characterised in that by following weight meter Material medicine is made:Semen brassicae 9g, magnetite 9g, agalloch eaglewood 5g, rhizoma zingiberis 5g, asarum 3g, Chinese cassia tree 5g, PLURONICS F87 3g, pool Lip river The husky 11g of nurse 407, azone 2g, glycerine 3g and water 50g.
3. the Chinese medicine compound prescription situ-gel for the treatment of cough and asthma according to claim 1, it is characterised in that by following weight meter Material medicine is made:Semen brassicae 5g, magnetite 5g, agalloch eaglewood 3g, rhizoma zingiberis 2g, asarum 2g, Chinese cassia tree 2g, PLURONICS F87 1g, pool Lip river The husky 5g of nurse 407, azone 0.5g, glycerine 1g and water 25g.
4. the Chinese medicine compound prescription situ-gel for the treatment of cough and asthma according to claim 1, it is characterised in that by following weight meter Material medicine is made:Semen brassicae 15g, magnetite 15g, agalloch eaglewood 10g, rhizoma zingiberis 9g, asarum 7g, Chinese cassia tree 9g, PLURONICS F87 8g, pool The 15g of Luo Shamu 407, azone 3g, glycerine 5g and water 80g.
5. the Chinese medicine compound prescription situ-gel for the treatment of cough and asthma according to claim 1, it is characterised in that by following weight meter Material medicine is made:Semen brassicae 3-9g, magnetite 6-8g, agalloch eaglewood 4-7g, rhizoma zingiberis 3-6g, asarum 1.5-2g, Chinese cassia tree 3-5g, Bo Luosha The 2-5g of nurse 188, poloxamer188 6-8g, azone 0.4-1.9g, glycerine 1-3g and water 25-50g.
6. the Chinese medicine compound prescription situ-gel for the treatment of cough and asthma according to claim 1, it is characterised in that by following weight meter Material medicine is made:Semen brassicae 10-15g, magnetite 9-15g, agalloch eaglewood 8-10g, rhizoma zingiberis 7-9g, asarum 2-3g, Chinese cassia tree 6-9g, pool Lip river The husky 6-8g of nurse 188, poloxamer188 9-15g, azone 2-3g, glycerine 3-5g and water 50-80g.
7. the preparation method of the Chinese medicine compound prescription situ-gel of the treatment cough and asthma described in claim 1 or any one of 2-6, its feature exist In comprising the following steps:
(1)The preparation of medicine:
Take rhizoma zingiberis, asarum, Chinese cassia tree, agalloch eaglewood to put in extraction kettle, extracting pressure 15Mpa, 30 DEG C of temperature, extract 3h;Temperature rises to 50 DEG C, pressure 15MPa, extract 2h;Pressure 25Mpa is adjusted, 30 DEG C of temperature, extracts 2h, collects extract, it is standby;
1-3g semen brassicaes are crushed, 100 mesh sieves is crossed, obtains semen brassicae powder, it is standby;4-12g semen brassicaes add the quality of 10 times of weight dense Spend and extracted 3 times, each 1h for 70% alcohol reflux, filtering, merging filtrate, reclaim ethanol, concentration, obtain semen brassicae medicinal extract, it is standby With;
Magnetite adds the water of 8 times of weight, and extraction twice, each 1.5h, filtering, merging filtrate, reclaims ethanol, concentration, obtains magnetite leaching Cream, it is standby;
(2)The preparation of situ-gel:
PLURONICS F87, poloxamer188 are slowly added in water, it is complete in 4 DEG C of swellings, mix, add above-mentioned extract, Semen brassicae powder, semen brassicae medicinal extract, magnetite medicinal extract, azone, glycerine, it is well mixed, produces.
CN201710707797.2A 2017-08-17 2017-08-17 A kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof Pending CN107441474A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710707797.2A CN107441474A (en) 2017-08-17 2017-08-17 A kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710707797.2A CN107441474A (en) 2017-08-17 2017-08-17 A kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107441474A true CN107441474A (en) 2017-12-08

Family

ID=60492362

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710707797.2A Pending CN107441474A (en) 2017-08-17 2017-08-17 A kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107441474A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1742992A (en) * 2004-08-31 2006-03-08 卢向东 Far-infrared xiaochuankang laster for treating asthma
CN101239175A (en) * 2008-03-10 2008-08-13 河南中医学院 Lung comforting plaster and preparation thereof
CN103285340A (en) * 2012-02-22 2013-09-11 河南中医学院 Acupuncture point applying medicament for treating chronic obstructive pulmonary disease
CN103830702A (en) * 2014-03-07 2014-06-04 河南中医学院 Acupoint paste for treating exogenous disease of infant
CN105770894A (en) * 2016-03-28 2016-07-20 中国人民解放军南京军区福州总医院 Aminolevulinic acid hydrochloride temperature-sensitive in-situ gel preparation and method for preparing same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1742992A (en) * 2004-08-31 2006-03-08 卢向东 Far-infrared xiaochuankang laster for treating asthma
CN101239175A (en) * 2008-03-10 2008-08-13 河南中医学院 Lung comforting plaster and preparation thereof
CN103285340A (en) * 2012-02-22 2013-09-11 河南中医学院 Acupuncture point applying medicament for treating chronic obstructive pulmonary disease
CN103830702A (en) * 2014-03-07 2014-06-04 河南中医学院 Acupoint paste for treating exogenous disease of infant
CN105770894A (en) * 2016-03-28 2016-07-20 中国人民解放军南京军区福州总医院 Aminolevulinic acid hydrochloride temperature-sensitive in-situ gel preparation and method for preparing same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
庞国明: "《亲献民间验方与特色疗法》", 31 August 2016, 中国中医药出版社 *
张学文: "《疑难病证治 第2版》", 30 June 1996, 人民卫生出版社 *

Similar Documents

Publication Publication Date Title
CN102028812B (en) Chinese medicinal preparation for treating allergic rhinitis, allergic asthma and urticaria and preparation method thereof
CN108014123A (en) Ozonize Chinese herbal medicine, Chinese medicine preparation extract
CN105030919A (en) Medicinal composition for treating cerebral hemorrhage
CN101143201A (en) Medicine for treating chronic obstructive lung disease and its preparation method
CN101810826B (en) Chinese medicament for treating liver cancer
CN106334171B (en) A kind of Chinese medicine preparation and preparation method for being used to repair hepatic injury
CN107441474A (en) A kind of Chinese medicine compound prescription situ-gel for treating cough and asthma and preparation method thereof
CN105902774A (en) Chinese medicinal composition, preparation method thereof and application in preparation of drugs for treatment of acute gouty arthritis
CN104688999A (en) Chinese herbal preparation for immunity enhancement
CN1330366C (en) Piles ointment and its preparation method
CN104013676B (en) Buddleja officinalis and application of extract thereof in drug preparation
CN104740579B (en) Premenstrual peace piece and its preparation technology
CN104758860B (en) A kind of Chinese medicine composition for treating allergic rhinitis Asthma Syndrome
CN104491316B (en) A kind of Chinese medicine preparation for the treatment of deficiency of QI in middle-JIAO type hyperplasia of prostate
CN102908607A (en) External traditional Chinese medicine for treating chronic simple rhinitis and preparation method thereof
CN117838819B (en) Traditional Chinese medicine composition for assisting chemical diuretics in treating ascites due to cirrhosis and application thereof
CN108096433A (en) Treat Chinese medicinal capsule of Senile Coronary Heart Disease syndrome of blood stasis due to qi deficiency and preparation method thereof
CN105998842A (en) Traditional Chinese medicine preparation for treating cholecystitis due to qi stagnation and blood stasis
CN106511957A (en) Traditional Chinese medicine composition for relieving fatigue
CN106138239A (en) A kind of Chinese medicine preparation treating chronic glomerulonephritis
CN100360157C (en) Medicine for treating boil, acute mastitis and acute inflammation
CN113499398A (en) Scheme for treating ESWL postoperative complications based on stranguria-treating and stasis-removing formula
CN103893285B (en) A kind of Chinese medicine composition is the application in nephrotoxicity and cardiovascular and cerebrovascular diseases medicament after preparation treatment chemicotherapy
CN107875198A (en) A kind of Chinese medicine composition for treating syphilis and preparation method thereof
CN102961680B (en) Traditional Chinese medicine preparation for treating gallstone and cholecystitis and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20171208